Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.

Tae Jung OhJae Myung YuKyung Wan MinHyun Shik SonMoon Kyu LeeKun Ho YoonYoung Duk SongJoong Yeol ParkIn Kyung JeongBong Soo ChaYong Seong KimSei Hyun BaikIn Joo KimDoo Man KimSung Rae KimKwan Woo LeeJeong Hyung ParkIn Kyu LeeTae Sun ParkSung Hee Choi Sung Woo Park

Published in: Diabetes & metabolism journal (2018)

Vogmet is a safe antihyperglycemic agent that controls blood glucose level effectively, yields weight loss, and is superior to metformin in terms of various key glycemic parameters without increasing the risk of hypoglycemia.

Keyphrases

blood glucose
glycemic control
weight loss
type diabetes
bariatric surgery
roux en y gastric bypass
gastric bypass
insulin resistance
blood pressure
body mass index
physical activity
metabolic syndrome
obese patients